Literature DB >> 9204746

Selective treatment of differentiated thyroid carcinoma.

E Gemsenjäger1, P U Heitz, B Martina.   

Abstract

Over a period of 20 years 84 papillary and 82 follicular carcinomas operated on by one surgeon and examined by one pathologist were documented prospectively, treated selectively, and followed for 1 to 20 years (median 7 years). Tumors with a low risk of recurrence or incurable disease-i.e., papillary carcinoma pT1-3 N0 M0 (n = 56) and minimally invasive follicular carcinoma (n = 37)-were treated by a limited-radicality hemithyroidectomy or total thyroidectomy without radioiodine in 79 of the 93 cases (85%). No unfavorable course was observed, and only one curable recurrence (1.3%) developed contralaterally after hemithyroidectomy for papillary cancer. Of the remaining 73 patients, including 100% of those with nodal involvement, 65 (89%) underwent total thyroidectomy with radioiodine. Total thyroidectomy was achieved in 34% of the cases by completion thyroidectomy, based on definitive histologic examination. No instance of a serious, potentially incurable recurrence and no tumor-related death was observed in patients with a papillary TNM stage I+II or with a minimally invasive follicular carcinoma. Five of the patients (6%) with papillary carcinoma, all with TNM stage III or IV, and seven of the patients (8.5%) with follicular carcinoma, all grossly invasive and pT3 or pT4, had tumor-related deaths following total thyroidectomy in all and with remnant ablation in 10 cases. A potentially curable node recurrence occurred in two patients 1 and 10 years, respectively, after primary treatment. Permanent hypoparathyroidism (n = 4) (2.4%) and permanent recurrent laryngeal nerve palsy (n = 2) (1.2%) were observed only in patients with a grossly invasive follicular carcinoma and concomitant benign recurrent goiter. We conclude that (1) hemithyroidectomy or total thyroidectomy without radioiodine is adequate for papillary carcinoma pT1-3 N0 and minimally invasive follicular carcinoma; (2) there were no nodal recurrences in tumors recognized as node-negative; and (3) extracapsular excision of one or both lobes can be carried out technically with low morbidity. The study confirms the prognostic value of age-related TNM classification for papillary carcinoma; classification of follicular thyroid carcinoma as minimally invasive or grossly invasive proved to be useful.

Entities:  

Mesh:

Year:  1997        PMID: 9204746     DOI: 10.1007/pl00012284

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  12 in total

1.  Comparison of prognostic scoring systems in follicular thyroid cancer.

Authors:  K W Teo; N K Yuan; W B Tan; R Parameswaran
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

2.  Minimally invasive follicular thyroid carcinoma.

Authors:  C S Heffess; L D Thompson
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 3.  [Minimally invasive follicular thyroid carcinoma : Not always total thyroidectomy].

Authors:  M Hermann; K Tonninger; F Kober; E-M Furtlehner; A Schultheis; N Neuhold
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

4.  Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.

Authors:  Samuel Golpanian; Eduardo A Perez; Jun Tashiro; John I Lew; Juan E Sola; Anthony R Hogan
Journal:  Pediatr Surg Int       Date:  2015-12-30       Impact factor: 1.827

5.  Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.

Authors:  Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

6.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

7.  Pathological characteristics and clinical perspectives of papillary thyroid cancer: study of 714 patients.

Authors:  Davor Džepina; Krešo Zurak; Vlado Petric; Hrvoje Čupić
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

8.  Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts.

Authors:  Paolo Miccoli; Michele N Minuto; Clara Ugolini; Erica Panicucci; Piero Berti; Marco Massi; Fulvio Basolo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

9.  Risk-stratified management of well-differentiated thyroid cancers: a review of experience from a single institution, 1990-2003.

Authors:  M H Chew; G Chan; M M A Siddiqui; B C Tai; R Sivanandan; K C Soo; D T H Lim
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

10.  Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer.

Authors:  Samuel Chan; Katarina Karamali; Anna Kolodziejczyk; Georgios Oikonomou; John Watkinson; Vinidh Paleri; Iain Nixon; Dae Kim
Journal:  Eur Thyroid J       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.